CYBREX AMIKACIN— 510(k) K802669

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K802669 for CYBREX AMIKACIN, Substantially Equivalent on 1980-11-12. Applicant: Abbott Laboratories.

Clearance details

Applicant: Abbott Laboratories
Product code: Code KLQ
Advisory panel: Clinical Toxicology
Date received: 1980-10-27
Decision date: 1980-11-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.